SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Knowledge Extraction Technologies
ADK.V 0.350-3.4%Oct 29 3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
From: Baywall1/16/2017 2:20:18 PM
   of 4
 
Stock reached 20 cents today.--This 2016 contract covered ISSSTE's diabetic population from Mexico City and the metropolitan area. Over 71,000 diabetes patients were screened in record time in order to help prevent patients from going blind and accelerate referral for treatment to safeguard patients' health.

"Diagnos's artificial intelligence platform (CARA) delivered outstanding results during the screening operations, demonstrating the efficiency of our solution. The data collected will be very valuable to our clients in identifying further actions to be taken with their diabetic population. We would like to thank ISSSTE's leadership and the Mexican government for taking the lead in preventing blindness and trusting our artificial intelligence services, which will help reduce and streamline diabetes costs," said Andre Larente, chief executive officer of Diagnos.

ISSSTE is the health and social services institution for the federal government employees. It covers over 13 million people across the nation. For 2017, the objective is to work with ISSSTE and cover three times the volume of 2016 and to expand national coverage by supporting its MIDE flagship diabetes program.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext